Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1532 |
Pidotimod
|
Others; Antibacterial | Microbiology/Virology; Others |
Pidotimod 是一种具有免疫调节特性的合成二肽。它增加巨噬细胞活性和体液免疫功能。它可研究慢性支气管炎、慢性阻塞性肺疾病 、支气管扩张、慢性特发性荨麻疹等。 | |||
T22358 |
Etalocib
LY293111,VML295 |
Apoptosis; Leukotriene Receptor; LTR | Apoptosis; GPCR/G Protein; Immunology/Inflammation |
Etalocib (LY293111) 是一种具有口服活性的白三烯(LTB4)受体的拮抗剂,抑制 [3H]LTB4结合的 Ki 值为 25 nM。它还可诱导凋亡。它抑制 LTB4诱导的钙动员,lC50值为 20 nM。 | |||
T15543 |
IA-Alkyne
N-Hex-5-ynyl-2-iodo-acetamide,Iodoacetamide-alkyne |
TRP/TRPV Channel | Membrane transporter/Ion channel |
IA-Alkyne (Iodoacetamide-alkyne) 是TRP 通道 (TRPC) 的激动剂,有用于呼吸道感染相关疾病研究的潜力。IA-Alkyne 可以用于开发同位素标记的探针,在定量的半胱氨酸反应分析 (cysteine-reactivity)有应用的价值。 | |||
T34231 |
Quinterenol sulfate
CP-10,303-8,Quinprenaline sulfate,CP 10,303-8 |
||
Quinoline sulfate has a bronchiectasis effect on patients with asthma. | |||
T26737 |
Bamifylline Hydrochloride
BAX-2793Z,AC 3810,AC-3810,BAX2793Z,BAX 2793Z |
||
Bamifylline Hydrochloride, an adenosine A1 receptor antagonist, is uesd to treat bronchiectasis and chronic obstructive pulmonary disease. | |||
T70381 |
GSK2793660 free base
|
||
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. | |||
T34079 |
Pirbuterol Acetate
pirbuterol sulfate,EINECS 265-862-4,Maxair,Pirbuterol acetate (USAN) |
||
Pibuterol Acetate is a short-acting beta-2 adrenergic receptor agonist with bronchiectasis and is used as a respiratory activated quantitative inhaler in the treatment of asthma. | |||
T21680 |
A 68930 hydrochloride
|
||
A68930 hydrochloride 是一种多巴胺D1受体激动剂,可用于支气管扩张的研究。 | |||
T32156 |
Indimilast
|
||
Indimilast is used to inhibit phosphodiesterase IV that regulates lung inflammation and causes bronchiectasis by increasing intracellular cyclic adenosine 3', 5'-monophosphate in airway smooth muscle and inflammatory cells. Potential to treat chronic obst | |||
T11466 |
GSK-2793660
|
Others | Others |
GSK-2793660 是一种具有口服活性并且不可逆的组织蛋白酶 C (Cathepsin C;CTSC) 抑制剂。GSK-2793660 是一种生物活性肽,可用于支气管扩张的研究。 |